A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results. Supplementary Files
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://data.mendeley.com/datasets/f5jkpm4mxh
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Figures 1-6. Supplementary Tables 1-5
创建时间：
2021-03-16
